Collegium Pharmaceutical (COLL) Asset Utilization Ratio (2017 - 2026)

Collegium Pharmaceutical's Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.48 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 54.6% year-over-year to 0.48; the TTM figure through Mar 2026 stood at 0.48 (up 54.6% YoY), while the FY2025 annual figure was 0.47, up 4.5% from the prior year.
• Asset Utilization Ratio was 0.48 for Q1 2026 at Collegium Pharmaceutical, up from 0.48 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.53 in Q2 2024 to a low of 0.2 in Q2 2022.
• Historically, Asset Utilization Ratio has averaged 0.38 across 5 years, with a median of 0.44 in 2023.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio tumbled 59.11% in 2022, then soared 125.49% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.32 in 2022, then jumped by 51.11% to 0.49 in 2023, then sank by 40.4% to 0.29 in 2024, then surged by 64.3% to 0.48 in 2025, then increased by 0.64% to 0.48 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.48 (Q1 2026), 0.48 (Q4 2025), and 0.47 (Q3 2025), per Business Quant data.